Cyclin I protects podocytes from apoptosis

Siân V Griffin1, J Paul Olivier, Jeffrey W Pippin

  • 1Department of Medicine, Division of Nephrology, University of Washington School of Medicine, Seattle, 98195, USA.

Insights

Cyclin I deficiency in kidney podocytes increases their apoptosis and worsens kidney disease. Stabilizing p21(Cip1/Waf1) may protect these vital kidney cells.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Glomerular podocyte injury limits kidney regeneration, leading to glomerulosclerosis and renal failure.
  • Cyclin I is uniquely expressed in glomerular podocytes, suggesting a specific role in kidney function.

Purpose of the Study:

  • To investigate the biological function of cyclin I in glomerular podocytes.
  • To determine the role of cyclin I in podocyte apoptosis and its contribution to kidney disease.

Main Methods:

  • Generation and analysis of cyclin I knock-out ( -/- ) mice.
  • In vitro and in vivo assessment of podocyte apoptosis.
  • Experimental glomerulonephritis induction in wild-type and cyclin I -/- mice.
  • Analysis of p21(Cip1/Waf1) levels and half-life in cultured podocytes.

Main Results:

  • Cyclin I -/- podocytes exhibited increased apoptosis in vitro and in vivo.
  • Podocyte apoptosis was significantly elevated in cyclin I -/- mice following glomerulonephritis induction, correlating with reduced renal function.
  • p21(Cip1/Waf1) levels were lower and less stable in cyclin I -/- podocytes.
  • Enforced expression of p21(Cip1/Waf1) rescued cyclin I -/- podocytes from apoptosis.

Conclusions:

  • Cyclin I protects glomerular podocytes from apoptosis.
  • This protection is potentially mediated by cyclin I's role in stabilizing p21(Cip1/Waf1).
  • Targeting cyclin I or p21(Cip1/Waf1) may offer therapeutic strategies for kidney diseases involving podocyte injury.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...